Scholar rock appoints rebecca mcleod chief brand officer and u.s. general manager

Cambridge, mass.--(business wire)--scholar rock (nasdaq: srrk), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (sma) and other severe and debilitating neuromuscular diseases, today announced that rebecca mcleod has been appointed to the newly created role of chief brand officer and u.s. general manager. in this role, she will be responsible for leading the anticipated u.s. commercial launch of apitegromab fo.
GM Ratings Summary
GM Quant Ranking